Images List Premium Download Classic

Immunotherapy

Immunotherapy-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Anti-gitr antibodies for cancer diagnostics
Bristol-myers Squibb Company
June 14, 2018 - N°20180164321

Provided herein are diagnostic antibodies that bind to glucocorticoid-induced tumor necrosis factor receptor (gitr). Such antibodies are useful for methods of detecting the expression of gitr in biological samples, for example, tumor tissue, and identifying a cancer patient likely to respond to anti-gitr immunotherapy or predicting whether a cancer patient will respond to anti-gitr immunotherapy..
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene wt1
Vaximm Ag
June 14, 2018 - N°20180163169

The present invention relates to an attenuated mutant strain of salmonella comprising a recombinant dna molecule encoding wilms' tumor protein i. In particular, the present invention relates to the use of said attenuated mutant strain of salmonella in cancer immunotherapy..
Size tunable microbial mimetics for immunotherapy of thyroid carcinomas and solid tumors
June 14, 2018 - N°20180161433

The microbial mimetics exhibit unique properties, including size tunability and contain antigenic cargo complexed to immune stimulatory molecules, which synergize to potentiate immune responses. The mm constitute a versatile platform for triggering immune responses against cells expressing epitopes contained within the complexed antigenic cargo..
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions for cellular immunotherapy
Fred Hutchinson Cancer Research Center
June 14, 2018 - N°20180161369

The present disclosure relates to compositions and methods for using cells having cellular immunotherapies comprising a composition of chimeric antigen receptor (car)-modified cd4+ t cells and a composition of cd8+ t cells modified with a distinct car in that the intracellular signaling component of the each car is different, wherein the modified cd4+ and cd8+ t cells have enhanced ...
Immunotherapeutic methods using irreversible electroporation
Virginia Tech Intellectual Properties, Inc.
June 14, 2018 - N°20180161086

Methods for treating tissue with irreversible electroporation and immunotherapy are described. The methods include placing a probe in tissue within a human body, wherein the probe has at least a first electrode, applying a plurality of electrical pulses through the first electrode and a second electrode, causing irreversible electroporation (ire) of the tissue within a target ablation zone, and administering ...
Method for generating human dendritic cells for immunotherapy
The Regents Of The University Of California
June 07, 2018 - N°20180155688

In various embodiments methods of producing a cell population enriched for clec9a+ dendritic cells are provided where the methods involve culturing stem cells and/or progenitor cells in a cell culture comprising culture medium, a notch ligand, stem cell factor (scf), flt3 ligand (flt3l); thrombopoietin (tpo); and il-3 and/or gmcsf.. .
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Normal tissue toxicity reducing microbeam-broadbeam radiotherapy, skin's radio-response immunotherapy and mutated molecular apheresis combined cancer ...
June 07, 2018 - N°20180154183

Normal tissue complications limit curative broadbeam radiotherapy to tumors including lung cancer. Radiation retinitis causing blindness limits quality of life and long term survival for patients with ocular melanoma.
Novel cmv pp65 targeting dna vaccine for cancer immunotherapy
Vaximm Ag
June 07, 2018 - N°20180153976

The present invention relates to an attenuated strain of salmonella comprising a dna molecule encoding cmv pp65. In particular, the present invention relates to the use of said attenuated strain of salmonella in cancer immunotherapy..
Combination compositions for immunotherapy
Curegenix Corporation
June 07, 2018 - N°20180153884

The present invention relates to therapeutic combinations comprising wnt inhibitors and methods for treating cancers using combination therapy.. .
Nanoparticles for photodynamic therapy, x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any ...
The University Of Chicago
June 07, 2018 - N°20180153796

Metal-organic frameworks (mofs) comprising photosensitizers are described. The mofs can also include moieties capable of absorbing x-rays or other ionizing irradiation energy and/or scintillation.
Methods of using bispecific cd33 and cd3 binding proteins
Amphivena Therapeutics, Inc.
May 31, 2018 - N°20180148507

Described herein are binding proteins that specifically bind to human cd33, and in particular to bispecific binding proteins that specifically bind to human cd33 and human cd3. Also described herein are bispecific tandem diabodies that bind to cd33 and cd33, and their uses for immunotherapy of cd33+ cancers, diseases and conditions such as acute myeloid leukemia (aml)..
Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies
National University Of Singapore
May 31, 2018 - N°20180148506

The present invention provides compositions comprising an anti-cd7 chimeric activating receptor (car) and an anti-cd7 protein expression blocker, and methods of using such compositions in cancer therapy.. .
Immobilized poly(n)polymerase
Curevac Ag
May 24, 2018 - N°20180142275

The present invention relates to an immobilized poly(n)polymerase (pnp), methods of producing said pnp and uses thereof. Further disclosed is an enzyme reactor and kit comprising the pnp for producing polynucleotidylated ribonucleic acid poly(n)rna)molecules which are useful in gene therapy, immunotherapy, protein replacement therapy and/or vaccination..
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
May 24, 2018 - N°20180142257

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.. .
Novel peptides and combination of peptides for use in immunotherapy against various tumors
Immatics Biotechnologies Gmbh
May 24, 2018 - N°20180141993

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Self assembling molecules for targeted drug delivery
The General Hospital Corporation
May 24, 2018 - N°20180140719

Described herein are self-assembling protein molecules for delivering a payload, for example, a toxic anti-cancer agent, a cancer immunotherapy, a toxic anti-cancer agent and a cancer immunotherapy, or an imaging agent, to specific tissues. Examples of self-assembled proteins include clathrin and derivatives of clathrin..
Cd123 specific multi-chain chimeric antigen receptor
Cellectis
May 17, 2018 - N°20180134795

The present invention relates to a new generation of chimeric antigen receptors (car) referred to as multi-chain cars, which are made specific to the antigen cd123. Such cars aim to redirect immune cell specificity and reactivity toward malignant cells expressing the tumor antigen cd123.
Intradermal injection needle for immunotherapy
Terumo Kabushiki Kaisha
May 17, 2018 - N°20180133410

An intradermal injection needle is an intradermal injection needle assembly to be used by piercing the intradermal injection needle into the skin of a living body. The intradermal injection needle has a hollow needle having a blade edge pierceable into the skin and a discharge port of an administration product; and a hub holding the hollow needle.
Biological complexes and methods for using same
Adheren Incorporated
May 17, 2018 - N°20180133341

The disclosure provides complexes comprising targeting units, methods for their production, and methods for their use. In some embodiments, complexes comprise therapeutic agents complexed with targeting units.
Cancer immunotherapy using virus particles
Case Western Reserve University
May 17, 2018 - N°20180133304

A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.. .
Early cancer detection and enhanced immunotherapy
May 17, 2018 - N°20180133298

A method of therapy for a tumor or other pathology by administering a combination of thermotherapy, immunotherapy, and vaccination optionally combined with gene delivery. The combination therapy beneficially treats the tumor and prevents tumor recurrence, either locally or at a different site, by boosting the patient's immune response both at the time or original therapy and/or for later therapy.
Loading